This dose should be maintained for at least four weeks to assess tolerance and initial therapeutic response before considering further dose escalation
Fast access to science-backed GLP-1 weight loss medications delivered to your doorstep no in-person visits, no insurance hassle
Conversely, those with HbA1c values closer to target may see more modest improvements but may reach therapeutic goals more quickly
Underlying Conditions Fluid retention that is persistent, progressive, or accompanied by other symptoms can reflect underlying conditions that arent caused by semaglutide but may become more apparent as other aspects of health are being monitored
Quick Answer: On your first day of GLP-1 treatment, you will receive a subcutaneous injection at the lowest dose, with most patients experiencing minimal immediate effects and some noticing subtle appetite changes within 24 to 48 hours
Oral semaglutide has been tested in large clinical trials, including the OASIS 1 and Phase 3a studies